Severe pre-eclampsia and fetal growth restriction: longterm projections for mother and offspring


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To determine the impact of severe preeclampsia on peri- and neonatal outcomes, long-term prognosis for mother and offspring. Materials and methods. A retrospective cohort study including 123 women who had preeclampsia during a current pregnancy. 83 women had severe preeclampsia (PE) and 31 women of them had fetal growth restriction (FGR), the other 40 women had mild PE. The study also included their children who was born between 2012 and 2019. The women were followed for 5-7 years and their infants - for the first year of life. Results.The analysis of neonatal complications revealed statistically significant differences between the groups with severe and mild PE: respiratory distress syndrome (RDS) in newborns - 57.8% and 5%; congenital infectious and inflammatory diseases - 60.2% and 10% including congenital pneumonia in 59.03% and 7.5%. respectively; asphyxia - 18.1% and 7.5%; intraventricular hemorrhage -27.7% and 5%; cutaneous hemorrhagic syndrome -31% and 7.5%, respectively (p<0.05). In the first year of life, children from the group of severe PE had the most negative outcomes. Thus, cerebral palsy (CP) (OR=1,7), speech delay (OR=1,5) and neurotic reactions (OR=1,7), visual disorders (OR=3,2) were most common in this group. Conclusion. Women who had severe early preeclampsia during pregnancy had a threefold risk of developing hypertension and a twofold risk of metabolic syndrome compared to the control group 5-7 years after delivery. Morbidity and mortality of children were significantly higher in the group with severe early preeclampsia compared to mild PE.

Full Text

Restricted Access

About the authors

Elena. L Dolgopolova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: dolgopolovae93@mail.ru
PhD student

Natalia A. Lomova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: natasha-lomova@yandex.ru
PhD, Researcher of the Institute of Obstetrics

Anna L. Karavaeva

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: a_karavaeva@oparina4.ru
Head clinician of the Neonatal Department

Viktor V. Zubkov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_zubkov@oparina4.ru
MD, Director of the Institute of Neonatology

Roman G. Shmakov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
MD, Professor, Director of the Institute of Obstetrics

References

  1. NICE. National Institute for Health and Care Excellence. NICE guideline. Hypertension in pregnancy: diagnosis and management (NG133). 2019. Available at: www.nice.org.uk/guidance/ng133
  2. Madazli R., Yuksel M.A., Immamoglu M., Tuten A., Oncul M., Ay din B. et al. Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia. Arch. Gynecol. Obstet. 2014; 290(1): 53-7. https://dx.doi. org/10.1007/s00404-014-3176-x.
  3. Haddad B., Deis S., Goffinet F, Paniel B.J., Cabrol D., Siba B.M. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks’ gestation. Am. J. Obstet. Gynecol. 2004; 190(6): 1590-5; discussion 1595-7. https://dx.doi.org/10.1016/j.ajog.2004.03.050.
  4. Rezk M., Gamal A, Emara M. Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study. Hypertens. Pregnancy. 2015; 34(2): 137-44. https://dx.doi. org/10.3109/10641955.2014.982329.
  5. Davis E.F., Lazdam M., Lewandowski A.J., Worton S.A., Kelly B., Kenworthy Y. et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012; 129(6): e1552-61. https:// dx.doi.org/10.1542/peds.2011-3093.
  6. Hernandez-Diaz S., Toh S., Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009; 338: b2255. https://dx.doi.org/10.1136/bmj.b2255.
  7. Сковородина Т.В., Вишнякова П.А., Цвиркун Д.В., Шмаков Р.Г., Высоких М.Ю., Калачин К.А., Пырегов А.В. Влияние неинвазивной респираторной терапии у беременных с ранней тяжелой преэклампсией на уровни маркеров преэклампсии и митохондриальных DAMPs. Акушерство и гинекология. 2018; 10: 52-8. [Skovorodina T.V., Vishnyakova P.A., Tsvirkun D.V., Shmakov R.G., Vysokikh M.Yu., Kalachin K.A., Pyregov A.V. The impact of non-invasive respiratory therapy in pregnant women with early severe preeclampsia on the levels of preeclampsia markers and mitochondrial DAMPs. Obstetrics and Gynekology. 2018; 10: 52-8. (in Russian)]. https://dx.doi. org/10.18565/aig.2018.10.52-58
  8. Broekhuijsen K., van Baaren G.J., van Pampus M.G., Ganzevoort W., Sikkema J.M., Woiski M.D. et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015; 385(9986): 2492-501. https://dx.doi.org/10.1016/S0140-6736(14)61998-X.
  9. Koopmans C.M., Bijlenda D., Groen H., Mc Vijgen S., Aarnoudse J.G., Bekedam D.J. et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009; 374(9694): 979-88. https://dx.doi.org/10.1016/S0140-6736(09)60736-4.
  10. Odegard R.A., Vatten L.J., Nilsen S.T., Salvesen K.A., Austgulen R. Preeclampsia and fetal growth. Obstet. Gynecol. 2000; 96(6): 950-5.
  11. Harmon Q.E., Huang L., Umbach D.M., Klungsoyr K., Engel S.M., Magnus P. et al. Risk of fetal death with preeclampsia. Obstet. Gynecol. 2015; 125(3): 628-35. https://dx.doi.org/ 10.1097/AOG.0000000000000696.
  12. Pinheiro T.V., Brunetto S., Ramos J.G.L., Bernardi J.R., Goldani M.Z. Hypertensive disorders during pregnancy and health outcomes in the offspring: a systematic review. J. Dev. Orig. Health Dis. 2016; 7(4): 391-407. https://dx.doi. org/10.1017/S2040174416000209.
  13. von Ehr J., von Versen-Hoynck F. Implications of maternal conditions and pregnancy course on offspring’s medical problems in adult life. Arch. Gynecol. Obstet. 2016; 294(4): 673-9. https://dx.doi.org/10.1007/s00404-016-4178-7.
  14. Kajantie E., Eriksson J.G., Osmond C., Thornburg K., Barker J.P. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke. 2009; 40(4): 1176-80. https://dx.doi.org/ 10.1161/ STROKEAHA.108.538025.
  15. Cheng S.W., Chou H.C., Tsou K.I., Fang L.J., Tsao PN. Delivery before 32 weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-year developmental outcome. Early Hum. Dev. 2004; 76(1): 39-46. https://dx.doi. org/ 10.1016/j.earlhumdev.2003.10.004.
  16. van Wassenaer A.G., Westera J., van Schie P.E.M., Houtzager B.A., Cranendonk A., de Groot L. et al. Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 2011; 204(6): 510. e1-9. https://dx.doi.org/ 10.1016/j. ajog.2011.02.032.
  17. Davis E.F., Lewandowski A.J., Aye C., Williamson W., Boardman H., Huang R.C. et al. Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: insights from a 20-year prospective follow-up birth cohort. BMJ Open. 2015; 5(6): e008136. https://dx.doi.org/10.1136/ bmjopen-2015-008136.
  18. Lykke J.A., Landorf-Roos J., Sibai B.M., Funai E.F., Triche E.W., Paidas M.J. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009; 53(6): 944-51. https://dx.doi.org/10.1161/HYPERTENSIONAHA.109.130765.
  19. Bellamy L., Casas J.P, Hingorani A.D., Wikkiams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007; 335(7627): 974. https://dx.doi.org/10.1136/ bmj.39335.385301.BE.
  20. Hermes W., Franx A., van Pampus M.G., Bloemenkamp K.W.M., Bots M.L., van der Post J.A. et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am. J. Obstet. Gynecol. 2013; 208(6): 474. e1-8. https://dx.doi.org/10.1016/j.ajog.2013.02.016.
  21. Veerbeek J.H.W., Hermes W., Breimer A.Y., van Rijn B.B., Koenen S.V., Mol B.W. et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015; 65(3): 600-6. https://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04850.
  22. Mongraw-Chaffin M.L., Cirillo P.M., Cohn B.A. Preeclamsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010; 56(1): 166-71. https://dx.doi.org/10.1161/ HYPERTENSI0NAHA.110.150078.
  23. Heida K.Y., Franx A., van Rijn B.B., Eijkemans M.J.C., Boer J.M.A., Verschuren M.W.M. et al. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus. Hypertension. 2015; 66(6): 1116-22. https://dx.doi.org/10.1161/ HYPERTENSI0NAHA.115.06005.
  24. Auger N., Fraser W.D., Schnitzer M., Leduc L., Healy-Profitos J., Paradis G. Recurrent pre-eclampsia and subsequent cardiovascular risk. Heart. 2017; 103(3): 235-43. https://dx.doi.org/10.1136/heartjnl-2016-309671.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies